Mumbai - Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) will announce results for the third quarter ending December 31, 2021 on January 31, 2022. These results will also be available on the Company website, www.sunpharma.com.
Earnings call (06.30 pm IST, January 31, 2022)
The Company will conduct an hour long call at 06.30 pm IST on January 31, 2022 where senior management will discuss the Company's performance and answer questions from participants. To participate in this conference call, please pre-register yourself on below link and dial the numbers provided below, five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.sunpharma.com. A transcript of this conference call will also be available on the website.
Summary of events
Event: Earnings conference call
Date and time: January 31, 2022
Telephone number/ website: www.sunpharma.com
06.30 pm IST, January 31, 2022
Universal Number: +91 22 6629 0049, +91 22 7194 5729
Via audio webcast, details of which will be made available on www.sunpharma.com
Preregistration details
DiamondPassRegistration
Replay of conference call
January 31, 2022 to
February 07, 2022
India: +91 22 7194 5757
India: +91 22 6663 5757
Code: 33582
Via audio webcast playback, details of which will be made available on www.sunpharma.com
Disclaimer:
Statements in this 'Document' describing the Company's objectives, projections, estimates, expectations, plans or predictions or industry conditions or events may be 'forward looking statements' within the meaning of applicable securities laws and regulations. Actual results, performance or achievements could differ materially from those expressed or implied. The Company undertakes no obligation to update or revise forward looking statements to reflect developments or circumstances that arise or to reflect the occurrence of unanticipated developments/circumstances after the date hereof.
About Sun Pharmaceutical Industries Limited (CIN - L24230GJ1993PLC019050):
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in over 100 countries across the world, at affordable prices. Its global presence is supported by manufacturing facilities spread across 6 continents and approved by multiple regulatory agencies, coupled with a multi- cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities across multiple R&D centers, with investments of approximately 6-7% of annual revenues in R&D.
Contact:
Investors
Nimish Desai
Tel: +91 22 4324 4324, Xtn 2778
Tel: +91 22 4324 2778
Mobile: +91-98203 30182
E mail: nimish.desai@sunpharma.com
Media
Gaurav Chugh
Tel: +91 22 4324 4324, Xtn 5373
Tel: +91 22 4324 5373
Mobile: +91 98104 71414
E mail: Gaurav.chugh@sunpharma.com
SUN PHARMACEUTICAL INDUSTRIES LTD. 
